Cleared Traditional

CANCER ANTIGEN CONTROL (K924061) - FDA 510(k) Clearance

Class I Immunology device.

K924061 · Polymedco, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1993
Decision
195d
Days
Class 1
Risk

K924061 is an FDA 510(k) clearance for the CANCER ANTIGEN CONTROL. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Polymedco, Inc. (Cortlandt Manor, US). The FDA issued a Cleared decision on February 23, 1993 after a review of 195 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Polymedco, Inc. devices

Submission Details

510(k) Number K924061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1992
Decision Date February 23, 1993
Days to Decision 195 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 104d · This submission: 195d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 672
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K924061.
ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MASTERCHECK
K992710 · Abbott Laboratories · Nov 1999
DADE IAC-X COMPREHENSIVE IMMUNOASSAY CONTROL
K912455 · Baxter Healthcare Corp · Aug 1991
DADE LIID-TROL TL TRI-LEVEL LIPID CONTROL
K911854 · Baxter Healthcare Corp · Jun 1991
QCLYTE PROTEIN BASED ISE CONTROL
K904968 · Baxter Healthcare Corp · Dec 1990
DADE(R) CSF.L, LIQ CEREBROSPIN FLUID CTRL LEV 1&2
K903933 · Baxter Healthcare Corp · Oct 1990
DADE IMMUNOASSAY CONTROLS, LEVELS I, II, III
K903566 · Baxter Healthcare Corp · Sep 1990